Amzak Health Investors

Amzak Health Investors is a New York-based private equity firm established in 2020, dedicated to investing in growth-oriented companies across the diverse healthcare sector. Their investment scope is broad, encompassing therapeutics, medical devices, diagnostics, and various healthcare services. The firm positions itself as a long-term partner, providing not only capital but also strategic support to management teams aiming to build leading businesses within the healthcare landscape. Their approach is characterized by flexibility, allowing them to pursue both control and significant minority investment positions, adapting to the specific needs and opportunities presented by their target companies.

The firm's investment criteria are well-defined, focusing on companies that demonstrate strong growth potential and established financial performance. Amzak Health Investors typically targets businesses with enterprise values ranging from $50 million to $500 million, indicating a preference for established, mid-market companies rather than early-stage startups. Furthermore, they seek companies generating substantial earnings, specifically those with an EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) between $5 million and $50 million. This financial discipline underscores their focus on profitable and scalable ventures within the healthcare ecosystem.

Regarding their capital deployment, Amzak Health Investors typically writes first checks ranging from $25 million to $100 million. This substantial investment size allows them to take meaningful stakes in their portfolio companies and provide significant capital for growth initiatives, acquisitions, or operational improvements. Their strategy emphasizes partnering with experienced management teams to drive value creation and foster sustainable growth, leveraging their deep industry expertise and operational insights. The firm's commitment to the healthcare sector, combined with its strategic and financial resources, positions it as a key player for mature, growth-stage healthcare companies seeking substantial private equity backing.